BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10187941)

  • 41. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Anticancer Res; 2002; 22(4):2377-83. PubMed ID: 12174930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transoral laser microsurgery for advanced laryngeal cancer.
    Hinni ML; Salassa JR; Grant DG; Pearson BW; Hayden RE; Martin A; Christiansen H; Haughey BH; Nussenbaum B; Steiner W
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1198-204. PubMed ID: 18086960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage treatment for recurrent oral squamous cell carcinoma.
    Sun GW; Tang EY; Yang XD; Hu QG
    J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New clinical staging system for carcinoma of nasal cavity].
    Hu WH; Zhao YL; Fang SH; Han F; Kuang GT; Liu H; Lu LX; Yan J
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):355-9. PubMed ID: 16117899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment.
    Dabrowski A; Skoczylas T; Ciechański A; Wallner G; Zinkiewicz K; Cwik G; Górczyński R; Borowski A
    Med Sci Monit; 2006 Oct; 12(10):CR409-15. PubMed ID: 17006399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Angiogenesis in laryngeal squamous carcinoma and its prognostic significance].
    Gorban' NA; Ten VP; Pankratov VA
    Vopr Onkol; 2009; 55(1):46-50. PubMed ID: 19435199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognostic factors identified by Cox multivariate analysis of surgically treated 1018 laryngeal cancer patients].
    Du Q; Ji WY; Guan C; Xu QY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):211-3. PubMed ID: 16875608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction.
    Schroeder U; Groppe D; Mueller RP; Guntinas-Lichius O
    Cancer; 2008 Aug; 113(4):758-64. PubMed ID: 18613074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
    Xie X; Clausen OP; Boysen M
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma.
    Han Z; Lin GJ; Chi FL; Wang SY; Huang JM; Liu HJ; Zhang LR
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):352-8. PubMed ID: 18984970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?
    Bell RB; Kademani D; Homer L; Dierks EJ; Potter BE
    J Oral Maxillofac Surg; 2007 Feb; 65(2):229-36. PubMed ID: 17236926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Significance of TNM clasification in prognostic evaluation of hepatocelluar carcinoma following surgical resection].
    Zhang Z; Wu M; Shen F
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):293-5. PubMed ID: 11776820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.